Literature DB >> 10925702

The human RNA helicase A (DDX9) gene maps to the prostate cancer susceptibility locus at chromosome band 1q25 and its pseudogene (DDX9P) to 13q22, respectively.

C G Lee1, T Eki, K Okumura, M Nogami, V da C Soares, Y Murakami, F Hanaoka, J Hurwitz.   

Abstract

RNA helicase A is the homolog of the Drosophila maleless protein, an essential factor involved in dosage compensation, and plays a crucial role in early development in mammals. Here, we have mapped the human RNA helicase A (DDX9) gene to the major susceptibility locus for prostate cancer at chromosome band 1q25, and its pseudogene (DDX9P) to the band 13q22 by fluorescence in situ hybridization, somatic cell hybrid analysis, and assignment of YAC clones, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10925702     DOI: 10.1023/b:scam.0000007138.44216.3a

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  10 in total

1.  Deregulation of Internal Ribosome Entry Site-Mediated p53 Translation in Cancer Cells with Defective p53 Response to DNA Damage.

Authors:  Marie-Jo Halaby; Benjamin R E Harris; W Keith Miskimins; Margot P Cleary; Da-Qing Yang
Journal:  Mol Cell Biol       Date:  2015-09-21       Impact factor: 4.272

2.  The mRNA encoding the JUND tumor suppressor detains nuclear RNA-binding proteins to assemble polysomes that are unaffected by mTOR.

Authors:  Gatikrushna Singh; Sarah E Fritz; Bradley Seufzer; Kathleen Boris-Lawrie
Journal:  J Biol Chem       Date:  2020-04-20       Impact factor: 5.157

3.  The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer.

Authors:  Lidia Chellini; Marco Pieraccioli; Claudio Sette; Maria Paola Paronetto
Journal:  J Exp Clin Cancer Res       Date:  2022-05-19

4.  Translational Control Protein 80 Stimulates IRES-Mediated Translation of p53 mRNA in Response to DNA Damage.

Authors:  Marie-Jo Halaby; Yan Li; Benjamin R Harris; Shuxia Jiang; W Keith Miskimins; Margot P Cleary; Da-Qing Yang
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

Review 5.  Targeting IRES-Mediated p53 Synthesis for Cancer Diagnosis and Therapeutics.

Authors:  Bai Ji; Benjamin R E Harris; Yahui Liu; Yibin Deng; Sergio A Gradilone; Margot P Cleary; Jianhua Liu; Da-Qing Yang
Journal:  Int J Mol Sci       Date:  2017-01-04       Impact factor: 5.923

Review 6.  The enigmatic helicase DHX9 and its association with the hallmarks of cancer.

Authors:  Chloe Gulliver; Ralf Hoffmann; George S Baillie
Journal:  Future Sci OA       Date:  2020-11-02

7.  Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC.

Authors:  Yongjie Xie; Yang Liu; Jinsheng Ding; Guangming Li; Bo Ni; Huifang Pang; Xin Hu; Liangliang Wu
Journal:  Front Cell Dev Biol       Date:  2022-02-14

Review 8.  DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation.

Authors:  Frances V Fuller-Pace
Journal:  Nucleic Acids Res       Date:  2006-08-25       Impact factor: 16.971

Review 9.  The biology of DHX9 and its potential as a therapeutic target.

Authors:  Teresa Lee; Jerry Pelletier
Journal:  Oncotarget       Date:  2016-07-05

Review 10.  The RNA helicase A in malignant transformation.

Authors:  Marco Fidaleo; Elisa De Paola; Maria Paola Paronetto
Journal:  Oncotarget       Date:  2016-05-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.